Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors

Kwasi Antwi, Galen Hostetter, Michael J. Demeure, Benjamin A. Katchman, G. Anton Decker, Yvette Ruiz, Timothy D. Sielaff, Lawrence J. Koep, Douglas Lake

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Blood circulates through nearly every organ including tumors. Therefore, plasma is a logical source to search for tumor-derived proteins and peptides. The challenge with plasma is that it is a complex bodily fluid composed of high concentrations of normal host proteins that obscure identification of tumor-derived molecules. To simplify plasma, we examined a low molecular weight (LMW) fraction (plasma peptidome) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods. In the plasma peptidome of patients with ductal adenocarcinoma of the pancreas (DAP), a prominent peptide was identified from the QSOX1 parent protein. This peptide is stable in whole blood over 24 h and was present in 16 of 23 DAP patients and 4 of 5 patients with intraductal papillary mucinous neoplasm (IPMN). QSOX1 peptides were never identified in the plasma peptidome from 42 normal healthy donors using the same methods. Immunohistochemical staining of DAP tissue sections with anti-QSOX1 antibody shows overexpression of QSOX1 in tumor but not in adjacent stroma or normal ducts. Three of four pancreas tumor cell lines also express QSOX1 protein by Western blot analysis. This is the first report of QSOX1 peptides in plasma from DAP patients and makes the rare connection between a peptide in plasma from cancer patients and overexpression of the parent protein in tumors.

Original languageEnglish (US)
Pages (from-to)4722-4731
Number of pages10
JournalJournal of Proteome Research
Volume8
Issue number10
DOIs
StatePublished - 2009

Fingerprint

Pancreatic Neoplasms
Tumors
Plasmas
Peptides
Pancreas
Neoplasms
Proteins
Adenocarcinoma
Blood
Liquid chromatography
Tandem Mass Spectrometry
Tumor Cell Line
Liquid Chromatography
Ducts
Mass spectrometry
Anti-Idiotypic Antibodies
Molecular Weight
Western Blotting
Molecular weight
Cells

Keywords

  • Collision-activated dissociation
  • Immunohistochemistry
  • Liquid chromatography
  • Pancreatic cancer
  • Peptidome
  • Plasma
  • Tandem mass spectrometry
  • Western blot

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)

Cite this

Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors. / Antwi, Kwasi; Hostetter, Galen; Demeure, Michael J.; Katchman, Benjamin A.; Decker, G. Anton; Ruiz, Yvette; Sielaff, Timothy D.; Koep, Lawrence J.; Lake, Douglas.

In: Journal of Proteome Research, Vol. 8, No. 10, 2009, p. 4722-4731.

Research output: Contribution to journalArticle

Antwi, Kwasi ; Hostetter, Galen ; Demeure, Michael J. ; Katchman, Benjamin A. ; Decker, G. Anton ; Ruiz, Yvette ; Sielaff, Timothy D. ; Koep, Lawrence J. ; Lake, Douglas. / Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors. In: Journal of Proteome Research. 2009 ; Vol. 8, No. 10. pp. 4722-4731.
@article{a3ef857affd64ca6864ea3bc45b7cc20,
title = "Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors",
abstract = "Blood circulates through nearly every organ including tumors. Therefore, plasma is a logical source to search for tumor-derived proteins and peptides. The challenge with plasma is that it is a complex bodily fluid composed of high concentrations of normal host proteins that obscure identification of tumor-derived molecules. To simplify plasma, we examined a low molecular weight (LMW) fraction (plasma peptidome) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods. In the plasma peptidome of patients with ductal adenocarcinoma of the pancreas (DAP), a prominent peptide was identified from the QSOX1 parent protein. This peptide is stable in whole blood over 24 h and was present in 16 of 23 DAP patients and 4 of 5 patients with intraductal papillary mucinous neoplasm (IPMN). QSOX1 peptides were never identified in the plasma peptidome from 42 normal healthy donors using the same methods. Immunohistochemical staining of DAP tissue sections with anti-QSOX1 antibody shows overexpression of QSOX1 in tumor but not in adjacent stroma or normal ducts. Three of four pancreas tumor cell lines also express QSOX1 protein by Western blot analysis. This is the first report of QSOX1 peptides in plasma from DAP patients and makes the rare connection between a peptide in plasma from cancer patients and overexpression of the parent protein in tumors.",
keywords = "Collision-activated dissociation, Immunohistochemistry, Liquid chromatography, Pancreatic cancer, Peptidome, Plasma, Tandem mass spectrometry, Western blot",
author = "Kwasi Antwi and Galen Hostetter and Demeure, {Michael J.} and Katchman, {Benjamin A.} and Decker, {G. Anton} and Yvette Ruiz and Sielaff, {Timothy D.} and Koep, {Lawrence J.} and Douglas Lake",
year = "2009",
doi = "10.1021/pr900414f",
language = "English (US)",
volume = "8",
pages = "4722--4731",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors

AU - Antwi, Kwasi

AU - Hostetter, Galen

AU - Demeure, Michael J.

AU - Katchman, Benjamin A.

AU - Decker, G. Anton

AU - Ruiz, Yvette

AU - Sielaff, Timothy D.

AU - Koep, Lawrence J.

AU - Lake, Douglas

PY - 2009

Y1 - 2009

N2 - Blood circulates through nearly every organ including tumors. Therefore, plasma is a logical source to search for tumor-derived proteins and peptides. The challenge with plasma is that it is a complex bodily fluid composed of high concentrations of normal host proteins that obscure identification of tumor-derived molecules. To simplify plasma, we examined a low molecular weight (LMW) fraction (plasma peptidome) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods. In the plasma peptidome of patients with ductal adenocarcinoma of the pancreas (DAP), a prominent peptide was identified from the QSOX1 parent protein. This peptide is stable in whole blood over 24 h and was present in 16 of 23 DAP patients and 4 of 5 patients with intraductal papillary mucinous neoplasm (IPMN). QSOX1 peptides were never identified in the plasma peptidome from 42 normal healthy donors using the same methods. Immunohistochemical staining of DAP tissue sections with anti-QSOX1 antibody shows overexpression of QSOX1 in tumor but not in adjacent stroma or normal ducts. Three of four pancreas tumor cell lines also express QSOX1 protein by Western blot analysis. This is the first report of QSOX1 peptides in plasma from DAP patients and makes the rare connection between a peptide in plasma from cancer patients and overexpression of the parent protein in tumors.

AB - Blood circulates through nearly every organ including tumors. Therefore, plasma is a logical source to search for tumor-derived proteins and peptides. The challenge with plasma is that it is a complex bodily fluid composed of high concentrations of normal host proteins that obscure identification of tumor-derived molecules. To simplify plasma, we examined a low molecular weight (LMW) fraction (plasma peptidome) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods. In the plasma peptidome of patients with ductal adenocarcinoma of the pancreas (DAP), a prominent peptide was identified from the QSOX1 parent protein. This peptide is stable in whole blood over 24 h and was present in 16 of 23 DAP patients and 4 of 5 patients with intraductal papillary mucinous neoplasm (IPMN). QSOX1 peptides were never identified in the plasma peptidome from 42 normal healthy donors using the same methods. Immunohistochemical staining of DAP tissue sections with anti-QSOX1 antibody shows overexpression of QSOX1 in tumor but not in adjacent stroma or normal ducts. Three of four pancreas tumor cell lines also express QSOX1 protein by Western blot analysis. This is the first report of QSOX1 peptides in plasma from DAP patients and makes the rare connection between a peptide in plasma from cancer patients and overexpression of the parent protein in tumors.

KW - Collision-activated dissociation

KW - Immunohistochemistry

KW - Liquid chromatography

KW - Pancreatic cancer

KW - Peptidome

KW - Plasma

KW - Tandem mass spectrometry

KW - Western blot

UR - http://www.scopus.com/inward/record.url?scp=70349976310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349976310&partnerID=8YFLogxK

U2 - 10.1021/pr900414f

DO - 10.1021/pr900414f

M3 - Article

C2 - 19795908

AN - SCOPUS:70349976310

VL - 8

SP - 4722

EP - 4731

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 10

ER -